Hint mode is switched on Switch off
For swift navigation between sections

LFB
LEI 969500W3S73ZWL7HPC72

PDF download

Choose all Reset all
Download Cancel
Organization name
Laboratoire francais du Fractionnement et des Biotechnologies
Country name
France
Country of registration
France
Industry
Miscellaneous Healthcare: Products and Services
Public debt
72 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Since it was formed in 1994, the LFB Group has been developing, manufacturing and marketing biological medicinal products. The LFB Group is now one of the leading European players in biopharmaceutical, its products are aimed at health professionals, mainly hospital based, these are medicinal products derived from living organisms in three major fields of therapy immunology, haemostasis and intensive care. LFB is a public company and the Group is growing in a competitive sector, with medicinal products sold in nearly 60 countries.

Awards

Documentation

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    969500W3S73ZWL7HPC72
  • NACE
    *** ***
  • NAICS
    *** ***
  • SIREN
    180036147
Registration is required to get access.